WAGNER CHARLES F JR (EVP and CFO) sold 6.1% of their position (3.25K shares) of VERTEX PHARMACEUTICALS INC / MA on the open market
Open‑market sale worth $1.48M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/30/2024ACC: 0000875320-24-000162
Officer· EVP and CFO
Since Apr 2019
-3.25K
Net shares
Net seller
$1.48M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.25K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.25K
Price / share
$454.79
Trade value
$1.48M
% of position
6.1%
5/28/2024
53.64K→50.39K
Total
Net shares
−3.25K
Net value
-$1.48M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/28/2024 | S · Sale | −3.25K | $454.79 | $1.48M | 6.1% | 53.64K | 50.39K |
| Total | −3.25K | -$1.48M | ||||||
Derivative Transactions0
No derivative transactions reported